OFIX
$12.03
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally.
Intraday
Recent News
Down 12.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Orthofix (OFIX)
Orthofix (OFIX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Orthofix Medical (OFIX) Narrative Shifts As Analysts Recut Targets And Profitability Timelines
Orthofix Medical has seen its modeled fair value price target trimmed from $19.25 to $17.25 per share, a move that places more attention on how analysts are recalibrating expectations. Recent commentary links these reduced targets to Q4 results, updated long term guidance, and a mix of constructive and cautious views on the company’s execution and growth path. As you read on, you will see how these shifting targets fit into the broader Orthofix story and what to watch as the narrative...
Orthofix Medical Inc. (OFIX) Target Reduced at Canaccord Following Q4 Results and 2026 Outlook Update
Orthofix Medical Inc. (NASDAQ:OFIX) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts. Orthofix Medical Inc. (NASDAQ:OFIX) is given the tenth position on our list of small-cap stocks. TheFly reported on February 26 that Canaccord reduced its price target for OFIX from $24 to $20 and gave it a Buy rating. […]
How The Orthofix Medical (OFIX) Narrative Is Shifting With Margin Delays And New 2026 Guidance
The latest research on Orthofix Medical comes with a lower fair value estimate, shifting from US$22.55 to US$19.25, roughly a 14.6% cut to the price target that anchors much of the current debate. Some analysts still see room for long term earnings power, while others focus on execution risk and the extended margin timeline, which helps explain why ratings and targets are not aligned. As you read on, you will see how these moving pieces shape the evolving Orthofix Medical story and what to...
Boyd Group Stock Up 20% Since $141 IPO as $9 Million Fund Bet Signals Conviction
Boyd Group Services runs collision repair and auto glass centers across North America, serving insurance companies and vehicle owners.